Search results for "Expression system"

showing 4 items of 4 documents

Interacción insecto-baculovirus. Aplicaciones en la mejora de baculovirus como vector para la expresión heteróloga de proteínas.

2018

Los baculovirus forman un amplio grupo de virus patógenos de insectos que se caracterizan por su elevada especificidad. Su principal aplicación es su uso como agente bioinsecticida frente a diferentes plagas agrícolas, aunque algunas de sus características han permitido el desarrollo de tecnologías que permiten usar los baculovirus como vectores para la expresión heteróloga de proteínas, así como vectores para su uso en terapia génica. El sistema de expresión basado en baculovirus, conocido como BEVS (Baculovirus Expression Vector System), fue desarrollado en los años 80 y desde entonces ha permitido la expresión de gran diversidad de proteínas recombinantes en cultivos celulares de insecto…

baculovirusvirusesUNESCO::CIENCIAS DE LA VIDABEVS:CIENCIAS DE LA VIDA [UNESCO]recombinant proteinexpression system
researchProduct

A self-inducible heterologous protein expression system in Escherichia coli

2016

AbstractEscherichia coli is an important experimental, medical and industrial cell factory for recombinant protein production. The inducible lac promoter is one of the most commonly used promoters for heterologous protein expression in E. coli. Isopropyl-β-D-thiogalactoside (IPTG) is currently the most efficient molecular inducer for regulating this promoter’s transcriptional activity. However, limitations have been observed in large-scale and microplate production, including toxicity, cost and culture monitoring. Here, we report the novel SILEX (Self-InducibLe Expression) system, which is a convenient, cost-effective alternative that does not require cell density monitoring or IPTG inducti…

0106 biological sciences0301 basic medicineExpression systemslac operonHeterologousGene ExpressionmechanismLac repressorBiology[ SDV.MP.BAC ] Life Sciences [q-bio]/Microbiology and Parasitology/Bacteriologymedicine.disease_cause01 natural sciencesArticlelaw.inventionApplied microbiologylactose03 medical and health scienceslawlac repressor010608 biotechnologyt1r3 taste receptor[SDV.BBM.GTP]Life Sciences [q-bio]/Biochemistry Molecular Biology/Genomics [q-bio.GN]Gene expressionmedicineEscherichia coliFood and NutritionInducerstationary-phaserecombinant geneinducerEscherichia coliMultidisciplinaryhsp70PromoterMolecular biology[SDV.MP.BAC]Life Sciences [q-bio]/Microbiology and Parasitology/BacteriologyRecombinant Proteins030104 developmental biologycloned genesBiochemistry[ SDV.BBM.GTP ] Life Sciences [q-bio]/Biochemistry Molecular Biology/Genomics [q-bio.GN]Alimentation et NutritionRecombinant DNA[SDV.BBM.GTP] Life Sciences [q-bio]/Biochemistry Molecular Biology/Genomics [q-bio.GN]bacteriophage-t7 rna-polymerase[SDV.MP.BAC] Life Sciences [q-bio]/Microbiology and Parasitology/Bacteriology
researchProduct

Strategies for the production of difficult-to-express full-length eukaryotic proteins using microbial cell factories : production of human alpha-gala…

2015

This work was supported by ERANET-IB08-007 project from the European Union and its linked national project EUI2008- 03610 to AV. We also appreciate the support from EME2007-08 to NFM from Universitat Autonoma de Barcelona, from Antartide 2010 to MLT and EP, from MIUR Azioni Integrate Italia-Spagna 2010 Prot. IT10LECLM9 to MLT, from MINECO (IT2009-0021) to AV and LT, from AGAUR (2009SGR-108) to AV. AV is also supported by The Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN, Spain), an initiative funded by the VI National R&D&i Plan 2008-2011, Iniciativa Ingenio 2010, Consolider Program, CIBER Actions and financed by the Instituto de Salud Car…

PseudoalteromonaRecombinant proteinExpression systemsFabry's diseaseHuman alpha-galactosidase AContext (language use)Computational biologyBiologymedicine.disease_causeApplied Microbiology and BiotechnologyMicrobiologyPseudoalteromonas haloplanktisGene expressionEnzyme StabilitymedicineProtein biosynthesisEscherichia coliHumansEscherichia coliGenePseudoalteromonas haloplanktis TAC125Expression systemGeneral Medicinebiology.organism_classificationRecombinant ProteinsPseudoalteromonasMembrane proteinFabry’s diseaseMetabolic Engineeringalpha-GalactosidaseProtein foldingBiotechnologyHuman
researchProduct

Encapsulation of the Bacillus thuringiensis secretable toxins Vip3Aa and Cry1Ia in Pseudomonas fluorescens

2013

Vip3A and Cry1I toxins are secreted during the vegetative growth of Bacillus thuringiensis. Vip3A toxins do not share homology to the crystal (Cry) proteins and are active against a different spectrum of lepidopteran species. Cry1I toxins share similarity with the Cry1 protein group but do not accumulate in the parasporal crystal. Since Vip3A and Cry1I toxins are released from the cell, they are excluded from biological formulates based on spores and crystals of B. thuringiensis. As an approach to obtain novel sprayable insecticides containing Vip3 or Cry1I toxins, Vip3Aa and Cry1Ia proteins were expressed in Pseudomonas fluorescens. This bacterium, non-pathogenic to animals or plants, can …

InsecticidesExpression vectorbiologyBacterial pathogenPseudomonas fluorescensHeterologous expression systemSpodopterabiology.organism_classificationmedicine.disease_causeMicrobial controlMicrobiologyInsect ScienceBacillus thuringiensismedicineBioassayHeterologous expressionAgronomy and Crop ScienceEscherichia coliCry proteinsBacteriaVip proteinsBiological Control
researchProduct